Guided Therapeutics P/E
What is the P/E of Guided Therapeutics?
The P/E of Guided Therapeutics, Inc. is N/A
What is the definition of P/E?
Price to earnings ratio is the ratio of a company’s stock price to the company’s earnings per share calculated over trailing twelve months.
= previous day’s close / ttm EPS
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E of companies in the Health Care sector on OTC compared to Guided Therapeutics
What does Guided Therapeutics do?
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Companies with p/e similar to Guided Therapeutics
- Reyna Silver has P/E of N/A
- EnGold Mines has P/E of N/A
- Superactive has P/E of N/A
- Paragon GmbH & Co. KGaA has P/E of N/A
- Cyclacel Pharmaceuticals has P/E of N/A
- Delivra Health Brands Inc has P/E of N/A
- Guided Therapeutics has P/E of N/A
- China Tianbao Development has P/E of N/A
- Tertiary Minerals plc has P/E of N/A
- Secure Property Development & Investment Plc has P/E of N/A
- Montagne et Neige Developpement SA has P/E of N/A
- Ximen Mining has P/E of N/A
- Nelson Resources has P/E of N/A